FDA approves Medtronic drug-coated stent

The FDA has granted Medtronic approval to market its Endeavor drug-coated stent in the U.S. The device is expected to compete with stents from Boston Scientific Corp. and Johnson & Johnson in the $2 billion market, which declined last year due to safety concerns. The company has increased its sales staff and began distributing the product Friday.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.) · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC